Честотата на животозастрашаващи (4 степен) хематологични нежелани реакции е била < 1, 0%, а честота на сепсиса – 1%.
The incidence of life threatening (Grade IV) haematologic effects was < 1.0% and sepsis was reported in 1% of patients.